Lantheus Announces AI Product Approval

Lantheus Logo

Lantheus announces the first and only FDA cleared AI-Enabled PSMA Digital Application.

Lantheus Holdings, Inc. announced that its subsidiary, EXINI Diagnostics AB, was granted 510(k) clearance by the U.S. Food and Drug Administration (FDA) for its digital application, aPROMISE (automated PROstate Cancer Molecular Imaging Standardized Evaluation). Read the full article here.


There are no comments yet

Leave a comment

Your email address will not be published. Required fields are marked *